Publication
Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al
Journal Paper/Review - Jan 22, 2016
Parker C, Gillessen Sommer Silke, Heidenreich A, Horwich A
Units
PubMed
Doi
Citation
Parker C, Gillessen Sommer S, Heidenreich A, Horwich A. Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al. Ann Oncol 2016; 27:750-1.
Type
Journal Paper/Review (English)
Journal
Ann Oncol 2016; 27
Publication Date
Jan 22, 2016
Issn Electronic
1569-8041
Pages
750-1